![](https://investorshub.advfn.com/uicon/564105.png?cb=1547105359)
Wednesday, May 12, 2021 12:58:34 PM
"Sufficient cash on hand for projected two years of runway, assuming
remaining Medtronic milestones are met in 2021"
So if for any reason MDT hasn't sealed the deal completely by then, we are still funded for operations into April 2023 (presentation date is 4/21/21), with IDE and patient follow-ups all projected to be completed by end of 2022. Therefore, allowing 4 months for the actual FDA application for marketing authorization, we are pretty much funded to the finish line.
On the other hand, the longer MDT waits to close the deal, the more risk they introduce to their own end game, as any other big player could step in with an offer.
No reason to be nervous, for sure!
Message in reply to:
Hard to be too nervous when I read this...
https://d1io3yog0oux5.cloudfront.net/_1b5da01e9503eaa779cd9b3664e79c01/titanmedicalinc/db/1086/9667/pdf/Titan-Medical-Overview-April-21-2021-FINAL.pdf
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM